Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anterix (ATEX) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Anterix (ATEX) over the last 11 years, with Q4 2025 value amounting to -$1000.0.

  • Anterix's Gains from Investment Securities changed N/A to -$1000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.0 million, marking a year-over-year decrease of 12969.0%. This contributed to the annual value of $6.0 million for FY2025, which is 6000.67% down from last year.
  • Per Anterix's latest filing, its Gains from Investment Securities stood at -$1000.0 for Q4 2025.
  • Over the past 5 years, Anterix's Gains from Investment Securities peaked at $20.0 million during Q1 2021, and registered a low of -$4.0 million during Q1 2025.
  • For the 5-year period, Anterix's Gains from Investment Securities averaged around $1.8 million, with its median value being -$2000.0 (2023).
  • Within the past 5 years, the most significant YoY rise in Anterix's Gains from Investment Securities was 3158888.89% (2021), while the steepest drop was 200000.0% (2021).
  • Over the past 5 years, Anterix's Gains from Investment Securities (Quarter) stood at -$57000.0 in 2021, then soared by 136.84% to $21000.0 in 2022, then plummeted by 114.29% to -$3000.0 in 2023, then skyrocketed by 333433.33% to $10.0 million in 2024, then plummeted by 100.01% to -$1000.0 in 2025.
  • Its Gains from Investment Securities stands at -$1000.0 for Q4 2025, versus -$21000.0 for Q3 2025 and $1.1 million for Q2 2025.